Michael Sia

936 total citations
25 papers, 196 citations indexed

About

Michael Sia is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Michael Sia has authored 25 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Radiation and 6 papers in Surgery. Recurrent topics in Michael Sia's work include Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (14 papers) and Advanced Radiotherapy Techniques (9 papers). Michael Sia is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (14 papers) and Advanced Radiotherapy Techniques (9 papers). Michael Sia collaborates with scholars based in Canada, United States and Spain. Michael Sia's co-authors include James D. Brierley, Tony Panzarella, Richard Tsang, Padraig Warde, Siraj Husain, Tara Rosewall, Tyler Meyer, Barry S. Rosenstein, Nelson N. Stone and Laura Fachal and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Michael Sia

24 papers receiving 195 citations

Peers

Michael Sia
Alan Pollack United States
Gary Mok Canada
Enya H.W. Ong Singapore
Jarey H. Wang United States
Crosby D. Rock United States
Michael Sia
Citations per year, relative to Michael Sia Michael Sia (= 1×) peers Detlef Imhoff

Countries citing papers authored by Michael Sia

Since Specialization
Citations

This map shows the geographic impact of Michael Sia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sia more than expected).

Fields of papers citing papers by Michael Sia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sia. The network helps show where Michael Sia may publish in the future.

Co-authorship network of co-authors of Michael Sia

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Sia. A scholar is included among the top collaborators of Michael Sia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Sia. Michael Sia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dayes, Ian S., Charles Catton, Amy Liu, et al.. (2025). Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer. European Urology Oncology. 9(1). 26–36. 1 indexed citations
2.
Roumeliotis, Michael, et al.. (2023). The transition in practice to reduce bolus use in post-mastectomy radiotherapy: A dosimetric study of skin and subcutaneous tissue. Medical dosimetry. 48(2). 113–117. 3 indexed citations
3.
Martell, Kevin, Michael Sia, Bimal Bhindi, et al.. (2022). Local Prostate Radiation Therapy and Symptomatic Local Events in De Novo Metastatic Prostate Cancer. Practical Radiation Oncology. 13(1). e61–e67. 2 indexed citations
5.
Quon, Harvey, Kundan Thind, Michael Sia, et al.. (2021). Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma. Clinical and Translational Radiation Oncology. 30. 38–42. 1 indexed citations
6.
Martell, Kevin, Harvey Quon, Sarah Quirk, et al.. (2020). Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19. Radiotherapy and Oncology. 151. 296–297. 3 indexed citations
7.
Taggar, Amandeep, Kevin Martell, Siraj Husain, et al.. (2018). Exposure to radiation and medical oncology training: A survey of Canadian urology residents and fellows. Canadian Urological Association Journal. 12(10). 321–325. 3 indexed citations
8.
Roy, Soumyajit, et al.. (2018). Integration of radiobiological modeling and indices in comparative plan evaluation: A study comparing VMAT and 3D-CRT in patients with NSCLC. Practical Radiation Oncology. 8(5). e355–e363. 5 indexed citations
9.
Martell, Kevin, Tyler Meyer, Michael Sia, Steve Angyalfi, & Siraj Husain. (2017). Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy. Journal of Contemporary Brachytherapy. 2(2). 99–105. 3 indexed citations
10.
Peacock, Michael, Kevin Martell, Amandeep Taggar, et al.. (2017). Institutional long-term outcomes at the first Canadian center performing intraoperatively planned low-dose-rate brachytherapy alone in low- and intermediate-risk prostate cancer. Brachytherapy. 16(4). 822–830. 10 indexed citations
11.
Alghamdi, Majed, Amandeep Taggar, Marc Kerba, et al.. (2016). An audit of referral and treatment patterns of high-risk prostate cancer patients in Alberta. Canadian Urological Association Journal. 10(11-12). 410–410.
12.
Taggar, Amandeep, Majed Alghamdi, Xanthoula Kostaras, et al.. (2016). Assessing guideline impact on referral patterns of postprostatectomy patients to radiation oncologists. Canadian Urological Association Journal. 10(9-10). 314–314. 3 indexed citations
13.
Watt, Elizabeth, Siraj Husain, Michael Sia, et al.. (2015). Dosimetric variations in permanent breast seed implant due to patient arm position. Brachytherapy. 14(6). 979–985. 5 indexed citations
14.
Kerns, Sarah L., Richard G. Stock, Nelson N. Stone, et al.. (2013). Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. Radiotherapy and Oncology. 107(3). 372–376. 57 indexed citations
15.
Sia, Michael, George Rodrigues, Cynthia Ménard, et al.. (2013). Treatment-related toxicity and symptom-related bother followingpostoperative radiotherapy for prostate cancer. Canadian Urological Association Journal. 4(2). 105–105. 4 indexed citations
16.
Sia, Michael, et al.. (2013). Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting. Canadian Urological Association Journal. 2(5). 500–500. 8 indexed citations
17.
Wu, Jackson, Penelope M. A. Brasher, Ali El‐Gayed, et al.. (2012). Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: Outcomes of 55Gy in 16 fractions at 3.4Gy per fraction. Radiotherapy and Oncology. 103(2). 210–216. 20 indexed citations
18.
Vesprini, Danny, Michael Sia, Gina Lockwood, et al.. (2011). Role of Principal Component Analysis in Predicting Toxicity in Prostate Cancer Patients Treated With Hypofractionated Intensity-Modulated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 81(4). e415–e421. 21 indexed citations
19.
Sia, Michael, Richard Tsang, Tony Panzarella, & James D. Brierley. (2010). Differentiated Thyroid Cancer with Extrathyroidal Extension: Prognosis and the Role of External Beam Radiotherapy. Journal of Thyroid Research. 2010. 1–7. 24 indexed citations
20.
Sia, Michael, Tara Rosewall, & Padraig Warde. (2008). Radiotherapy as Primary Treatment Modality. Frontiers of radiation therapy and oncology. 41. 15–25. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026